Trial Profile
Open – label, non randomized clinical study of Neoadjuvant chemotherapy with FOLFIRI and Avastin in patients with non-resectable liver metastases of colorectal cancer
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2012
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 11 Oct 2011 New trial record